Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06351085 · ClinicalTrials.gov registry record · NA

Enhancing Lung Cancer Screening Through Human-Centered Intervention

A NA study of Lung Cancer, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
2,869
Enrollment target
1
Study location

NCT06351085 is a NA study of Lung Cancer that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 2,869 participants, above the 929-participant average among 409 other Lung Cancer trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06351085, a NA study of Lung Cancer, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
2,869 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

Conditions Studied

Interventions

  • BEHAVIORAL Pre-Visit Planner
  • BEHAVIORAL Pre-Visit Planner + MyChart

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 2,869 participants
Start Date 2022-11-10
Est. Completion 2025-04-14
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT06351085

The ClinicalTrials.gov registry entry for NCT06351085 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,869 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 929-participant average among 409 other Lung Cancer trials with a reported enrollment target (209% higher). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Pre-Visit Planner is the first listed.

NCT06351085 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06351085 about?

NCT06351085 is a clinical study titled "Enhancing Lung Cancer Screening Through Human-Centered Intervention". The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

What is the current status of trial NCT06351085?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,869 participants. The study started on 2022-11-10. Estimated completion is 2025-04-14.

What conditions does trial NCT06351085 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06351085?

The interventions under investigation include: Pre-Visit Planner (BEHAVIORAL), Pre-Visit Planner + MyChart (BEHAVIORAL).

Who is sponsoring clinical trial NCT06351085?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06351085 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.